Drugs News and Research

RSS

‘I just want to stay in one spot’: From homeless to housed in rugged Del Norte

On a rainy winter morning, Jamie Hayden stopped in to visit with Diane Timothio. A case manager in Del Norte County on California's remote northern coast, Hayden comes by often, sometimes staying for hours, to work with Timothio.

18 Feb 2022

Advanced imaging reveals the loss of brain synapses in patients with mild symptoms of Alzheimer's

Advanced imaging technology developed by Yale researchers has helped them confirm that the destruction of brain synapses underlies the cognitive deficits experienced by patients with Alzheimer's disease, according to a study published Feb. 17 in the journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

17 Feb 2022

Trial of early antiviral therapy for COVID-19 shows no significant benefit

A new preprint research paper examines the efficacy of using three antivirals in various combinations in early infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Feb 2022

Ensitrelvir, a novel SARS-CoV-2 antiviral

S-217622 reduces the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters.

17 Feb 2022

Research shows alterations in transfer RNAs at the epigenetic level in cancer

A recently published paper in the journal Molecular Cancer by the group of Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, ICREA Research Professor and Genetics Chairman at the University of Barcelona, shows that transfer RNAs for certain amino acids are altered at the epigenetic level in some types of cancer, expressing it in an exaggerated manner in some cases and being deficient in others.

17 Feb 2022

New research shines light on mysterious dynamics that define the interplay between nerves and muscle

New research co-led by a University of Ottawa Faculty of Medicine professor is shedding light on some of the mysterious dynamics that define the interplay between nerves and muscle.

17 Feb 2022

COVID-19 survivors more likely to suffer from mental health problems

As the COVID-19 pandemic stretches into its third year, countless people have experienced varying degrees of uncertainty, isolation and mental health challenges.

17 Feb 2022

New METPlatform allows researchers to test drugs for possible use in brain metastases

It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer treatments.

17 Feb 2022

KHN’s ‘What the Health?’: It’s health costs, stupid (2022 edition)

The pandemic may be showing signs of winding down, but health care costs are not.

17 Feb 2022

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

Treating a tumor in the breast when distant metastases have already occurred does not improve outcomes in women with stage IV breast cancer, according to a new study published in the Journal of Clinical Oncology.

17 Feb 2022

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Hot flashes and night sweats are a common cause of insomnia among peri- and postmenopausal women. Hot flashes, night sweats and insomnia are all linked to reduced quality of life and distress.

17 Feb 2022

Combating leukemia cells by disrupting their energy maintenance mechanism

Acute myeloid leukemia, which affects blood and bone marrow cells, is a particularly dangerous form of cancer. More than half of patients under the age of 60 die.

17 Feb 2022

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

The present study entailed assessments of both infected and uninfected SOTRs against the D614G-CoV2 baseline virus and eight other variants.

17 Feb 2022

Researchers discover a novel group of proteins that exists in all domains of life

Proteins are the "workhorses" in every living cell and constitute the chemical basis of life. These little machines are required to turn food into energy, to manage motion and brain activities and to fight off bacteria and viruses.

17 Feb 2022

Skin cells outside of the hair follicles play large role in the development of a pimple

Acne is among the most common skin diseases in the United States, according to the American Academy of Dermatology Association, affecting up to 50 million Americans each year. It is also among the least studied.

17 Feb 2022

Search for a treatment to stop nerve cell degeneration yields promising results

Researchers at the University of Illinois Chicago found promising results in their search for a treatment to stop nerve cell degeneration that happens in some types of disorders, such as hereditary spastic paraplegia and Parkinson's disease, which can cause significant disability.

17 Feb 2022

Fortis Life Sciences Highlights First Year Success

Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced highlights from its first year of operations.

From Fortis Life Sciences 17 Feb 2022

Study helps understand actionable genetic variation affecting drugs in the Middle East population

A group of researchers at Qatar Foundation have reported the first comprehensive study of the distribution of actionable genetic variation affecting drugs in any Middle Eastern population, with potential implications for preemptive pharmacogenomic implementation in the region.

16 Feb 2022

Study analyzes trends in overdose deaths from use of non-benzodiazepines and gabapentinoids

With an alarming rise in the number of prescriptions filled for non-benzo sleeping/z-drugs and anti-epilepsy gabapentinoids over the last two decades, researchers at Columbia University Mailman School of Public Health aimed to fill in the gap in knowledge in the proportion of overdose deaths involving those medications and learn more about their co-usage with other substances across U.S. demographics categories.

16 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

Drugs News and Research

‘I just want to stay in one spot’: From homeless to housed in rugged Del Norte

Advanced imaging reveals the loss of brain synapses in patients with mild symptoms of Alzheimer's

Trial of early antiviral therapy for COVID-19 shows no significant benefit

Ensitrelvir, a novel SARS-CoV-2 antiviral

Research shows alterations in transfer RNAs at the epigenetic level in cancer

New research shines light on mysterious dynamics that define the interplay between nerves and muscle

COVID-19 survivors more likely to suffer from mental health problems

New METPlatform allows researchers to test drugs for possible use in brain metastases

KHN’s ‘What the Health?’: It’s health costs, stupid (2022 edition)

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Combating leukemia cells by disrupting their energy maintenance mechanism

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

Researchers discover a novel group of proteins that exists in all domains of life

Skin cells outside of the hair follicles play large role in the development of a pimple

Search for a treatment to stop nerve cell degeneration yields promising results

Fortis Life Sciences Highlights First Year Success

Study helps understand actionable genetic variation affecting drugs in the Middle East population

Study analyzes trends in overdose deaths from use of non-benzodiazepines and gabapentinoids

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News